Adia takes minority stake in USD 18.3 bn Hologic buyout: The Abu Dhabi Investment Authority (Adia) and Singapore’s GIC will join Blackstone and TPG as significant minority investors in the USD 18.3 bn acquisition of US-based women’s health firm Hologic, according to a company statement. The transaction, which includes debt, is the largest in the medical devices sector in nearly two decades.

The details: Under the agreement, Hologic shareholders will receive USD 76 per share in banknotes plus a USD 3 contingent value right, tied to revenue goals for its breast health business in 2026-2027. This marks a 6% premium to its last closing price. It will also receive debt financing from Citi, Bank of America, Barclays, Bank of Canada, and Sumitomo Mitsui Banking.

Second time’s the charm? Hologic had previously rejected a USD 16 bn takeover by Blackstone and TPG earlier this year.

Timeline: The transaction — approved by Hologic’s board — includes a 45-day go-shop period for the health firm to seek other takeover agreements, though if this one goes through, the agreement could close in 1H 2026, pending shareholder and regulatory approval.

Once complete, Hologic will be delisted from Nasdaq but retain its name and Massachusetts headquarters. The firms plan to accelerate research, pursue acquisitions and develop products, Reuters quotes people familiar with the matter as saying.

REMEMBER- Adia and Blackstone ties run deep: The two previously partnered with Vista Equity to acquire software provider Smartsheet for USD 8.4 bn last year and were in talks for a for a 20% stake in India’s Haldiram Snacks valued at USD 1.6 bn before they fell through on valuation differences.

ADVISORS- Goldman Sachs is acting as financial advisor to Hologic, while Wachtell, Lipton, Rosen & Katz is serving as counsel to the Company. Citi is financial advisor for the Blackstone-and-TPG-led consortium, while Kirkland & Ellis is serving as counsel, and Ropes & Gray is serving as healthcare regulatory counsel.

Tags: